{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-051424","form_type":"8-K","ticker":"CNTA","cik":"0001847903","company_name":"Centessa Pharmaceuticals plc","filed_at":"2026-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.524013+00:00","generated_at":"2026-05-16T02:49:38.549661+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Centessa finalizes advisory and separation pacts with former CEO Saha","bullets":["Saurabh Saha stepped down as CEO on Jan 1, 2026; advisory agreement signed Feb 9, 2026.","Advisory fee of $376/hour for initial six-month term, renewable automatically.","Separation provides vesting of equity through Feb 2, 2026; later equity forfeited.","Subject to Compensation Committee approval, Saha eligible for 100% of 2025 target bonus.","Vested equity exercise window extends to three months after advisory agreement ends."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-051424","json":"https://secwatch.observer/filing/0001193125-26-051424.json","markdown":"https://secwatch.observer/filing/0001193125-26-051424.md","text":"https://secwatch.observer/filing/0001193125-26-051424.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526051424/0001193125-26-051424-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526051424/d932267d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:49:38.549661+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}